Honokiol Inhibits SARS-CoV-2 Replication in Cell Culture at a Post-Entry Step

Researchers determined that honokiol protected Vero E6 cells from SARS-CoV-2-mediated cytopathic effect, with a 50% effective concentration of 7.8 μM.